MGRX Historical PE Ratio Notes

— Mangoceuticals, Inc. (ticker: MGRX) is a healthcare company focused on developing, marketing, and selling innovative men’s health and wellness products, with a particular emphasis on sexual health, such as prescription erectile dysfunction (ED) medications. Their business model blends telehealth services with direct-to-consumer online sales, allowing customers to consult with licensed providers and receive customized treatments discreetly. When examining MGRX’s historical price-to-earnings (PE) ratio, keep in mind that, as a growth-stage company in a competitive and highly regulated sector, earnings can be volatile or even negative during periods of heavy investment in customer acquisition, marketing, and product development. This can result in a high or undefined PE ratio, especially in the early stages after the company went public, when revenue growth expectations may significantly outpace actual profits. As you review historical charts and tables of price, earnings, & PE ratio, consider how investor sentiment, regulatory developments, commercialization milestones, & the company’s ability to expand its product offerings and subscriber base have influenced valuation multiples over time.

On this page we presented the MGRX Historical PE Ratio information for Mangoceuticals' stock. The average MGRX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MGRX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MGRX historical PE result, against the recent PE: when this page was posted on 5/19/2026, the most recent closing price for MGRX had been 0.41, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on MGRX or any other given stock, valuation analysis for MGRX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Mangoceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MGRX. Thanks for visiting, and the next time you need to research MGRX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.